Lilly cuts mid-stage heart failure and chronic kidney drugnews2025-01-28T23:15:44+00:00January 28th, 2025|Endpoints News|
AstraZeneca, Daiichi Sankyo bring Enhertu to HER2-ultralow settingnews2025-01-28T20:29:08+00:00January 28th, 2025|Endpoints News|
Ozempic label expanded to include reduced risk of worsening kidney diseasenews2025-01-28T20:27:28+00:00January 28th, 2025|Endpoints News|
Novo Nordisk asks Third Circuit to expedite IRA casenews2025-01-28T20:19:25+00:00January 28th, 2025|Endpoints News|
Sarepta shares two-year DMD data that may inform Europe decisionnews2025-01-27T20:36:39+00:00January 27th, 2025|Endpoints News|
Pharmacy middlemen lose bid to toss new Hawaii complaintnews2025-01-27T20:36:35+00:00January 27th, 2025|Endpoints News|
Pfizer inks $60M settlement to close Nurtec anti-kickback suitnews2025-01-27T19:33:49+00:00January 27th, 2025|Endpoints News|
Sage rejects Biogen’s deal offer, will look at other optionsnews2025-01-27T16:22:18+00:00January 27th, 2025|Endpoints News|
#ASCOGI25: Bristol Myers shares IO combo data in colorectal cancer; Pfizer still waiting on Braftovi regimen survival figuresnews2025-01-27T16:06:27+00:00January 27th, 2025|Endpoints News|
Trump healthcare transition: Live updates, biotech, pharma newsnews2025-01-27T16:00:12+00:00January 27th, 2025|Endpoints News|
